Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

0(0%)

Results Posted

83%(5 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_3

71%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 3Large-scale testing

5(83.3%)

Phase 4Post-market surveillance

1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(1)

Detailed Status

Completed6

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 4

Trials by Phase

Phase 35 (83.3%)

Phase 41 (16.7%)

Trials by Status

completed686%

terminated114%

Recent Activity

0 active trials

Showing 5 of 7

completed

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

NCT07362498

terminatedphase_3

Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

NCT04368910

completedphase_3

Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients

NCT00541385

completedphase_3

Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients

NCT00422084

completedphase_3

Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria

NCT00440999

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT07362498

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

Completed

NCT04368910Phase 3

Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients

Completed

NCT00440999Phase 3

Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria

Completed

NCT00403260Phase 3

Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients

Completed

NCT03201770Phase 4

Cohort Event Monitoring Study of Pyramax®

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7